panaxydol has been researched along with dactinomycin in 1 studies
Studies (panaxydol) | Trials (panaxydol) | Recent Studies (post-2010) (panaxydol) | Studies (dactinomycin) | Trials (dactinomycin) | Recent Studies (post-2010) (dactinomycin) |
---|---|---|---|---|---|
30 | 1 | 14 | 19,045 | 355 | 969 |
Protein | Taxonomy | panaxydol (IC50) | dactinomycin (IC50) |
---|---|---|---|
RAD51 | Homo sapiens (human) | 32.1 | |
Growth factor receptor-bound protein 2 | Homo sapiens (human) | 5 | |
Discoidin domain-containing receptor 2 | Homo sapiens (human) | 9 | |
Growth factor receptor-bound protein 2 | Mus musculus (house mouse) | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, HS; Moon, J; Sohn, J; Yu, SJ | 1 |
1 other study(ies) available for panaxydol and dactinomycin
Article | Year |
---|---|
Induction of G(1) cell cycle arrest and p27(KIP1) increase by panaxydol isolated from Panax ginseng.
Topics: Alkynes; Antineoplastic Agents, Phytogenic; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cycloheximide; Dactinomycin; Diynes; Fatty Alcohols; G1 Phase; Humans; Microtubule-Associated Proteins; Panax; Plants, Medicinal; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2000 |